CPIX
Cumberland Pharmaceuticals Inc.
CPIX lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
CPIX Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Strong |
CPIX's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
CPIX PE Valuation
CPIX has no meaningful PE right now: it lost money over the past year.
CPIX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CPIX's losses to shrink, with revenue growing.
CPIX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.73 | -$0.51 |
| Q1 2026 | -$0.49 | -$0.24 |
| Q4 2025 | -$0.19 | +$0.28 |
| Q3 2025 | -$0.24 | +$0.53 |
| Q2 2025 | -$0.22 | +$0.51 |
| Q1 2025 | -$0.25 | +$0.34 |
| Q4 2024 | -$0.47 | -$0.03 |
| Q3 2024 | -$0.77 | -$0.60 |
CPIX lost $0.73 per share over the past year, a bigger loss than the year before.
CPIX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.8M | -19% |
| Q1 2026 | $9.1M | -22% |
| Q4 2025 | $13.7M | +31% |
| Q3 2025 | $8.3M | -8.7% |
| Q2 2025 | $10.8M | +10% |
| Q1 2025 | $11.7M | +38% |
| Q4 2024 | $10.4M | +12% |
| Q3 2024 | $9.1M | -9.9% |
CPIX's revenue is shrinking: $9M last quarter, down 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -36% | -29 points |
| Q1 2026 | -34% | -45 points |
| Q4 2025 | -10% | +7.6 points |
| Q3 2025 | -24% | -5.1 points |
| Q2 2025 | -6.9% | +3.5 points |
| Q1 2025 | 11% | +33 points |
| Q4 2024 | -18% | +48 points |
| Q3 2024 | -19% | -0.1 points |
CPIX's operating margin was −36% last quarter, down 29 points from the same quarter a year ago, near the bottom of its range since 2019.
CPIX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $130.5K | -84% |
| Q1 2026 | $387K | -90% |
| Q4 2025 | $3K | -100% |
| Q3 2025 | $163.4K | -64% |
| Q2 2025 | $817.3K | +$1.7M |
| Q1 2025 | $3.9M | +$6M |
| Q4 2024 | $1.9M | +92% |
| Q3 2024 | $460.1K | -61% |
CPIX still generates free cash flow, though less than at its 2023 peak: $683,899 over the past year.
CPIX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -4.6x | Net Cash |
| Q3 2025 | -7.5x | Net Cash |
| Q2 2025 | -6.4x | Net Cash |
| Q1 2025 | -6.5x | Net Cash |
| Q2 2023 | -11.7x | Net Cash |
| Q4 2019 | -12.4x | Net Cash |
CPIX has more cash than debt.
CPIX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 26.9 | Neutral |
CPIX's weekly RSI is 51 (neutral) and its Stochastic is 27 (neutral).
CPIX PE vs Healthcare Sector
CPIX has no meaningful PE right now: it lost money over the past year.
CPIX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.78 | 2.2% below |
| 20 week MA | $6.94 | 4.5% below |
| 50 week MA | $5.33 | 24% above |
| 100 week MA | $4.51 | 47% above |
| 200 week MA | $3.12 | 113% above |
CPIX has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 113% above its 200-week average.
CPIX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.14 | $3.06 | -40% |
| 2021 | $3.06 | $5.12 | +67% |
| 2022 | $5.12 | $2.11 | -59% |
| 2023 | $2.11 | $1.79 | -15% |
| 2024 | $1.79 | $2.32 | +30% |
| 2025 | $2.32 | $4.12 | +78% |
| 2026 YTD | $4.12 | $6.63 | +61% |
CPIX is up 61% so far in 2026, after finishing lower in three of the previous six years.